Jessimar Sanchez, MD
Pulmonary Disease · Wayne, NJNPI 1376036442
Payments from drug & device makers
Across 94 payments — averaging $49.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- AstraZeneca$1K
- GSK$479
- Sanofi$161
- United Therapeutics Corporation$119
- Viatris Specialty LLC$80
- plus $454 from 13 others
What the payments were for
- Travel & lodging$2,27749%
- Food & beverage$2,32850%
- Education$792%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $2,277 |
| AstraZeneca | 21 | $1,115 |
| GSK | 29 | $479 |
| Sanofi | 4 | $161 |
| United Therapeutics Corporation | 6 | $119 |
| Viatris Specialty LLC | 4 | $80 |
| Sanofi-aventis U.S. LLC | 1 | $79 |
| ANI Pharmaceuticals, Inc. | 5 | $79 |
| Insmed, Inc. | 4 | $63 |
| Amgen | 3 | $49 |
| ZOLL Respicardia, Inc. | 1 | $30 |
| Optinose US, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Pulmonx Corporation | 1 | $20 |
| Grifols USA, LLC | 1 | $20 |
| Inogen, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Verona Pharma, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,684 in reported general payments places this provider in the 65th percentile of 472 pulmonary disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $449 |
| Fluticasone Propionate | 14 | $139 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Wayne
- Reynold PanettieriNew Brunswick$2.5M
- Vinay SikandToms River$1.8M
- Stanley FielMorristown$1.3M
- Joseph HoffmanPark Ridge$1.1M
- Robert SussmanSummit$645K
- Ronaldo GoHackensack$563K
- Deborah GossHackensack$558K
- Sabina HussainNew Brunswick$555K
- Manuel CunananMillville$489K
- Emanuele SantomauroHackensack$420K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.